| Product Code: ETC12463365 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Imatinib Drug Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 China Imatinib Drug Market - Industry Life Cycle |
3.4 China Imatinib Drug Market - Porter's Five Forces |
3.5 China Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 China Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 China Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 China Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in China |
4.2.2 Growing awareness and adoption of targeted cancer therapies |
4.2.3 Favorable government initiatives and policies supporting cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with imatinib treatment |
4.3.2 Stringent regulatory requirements for drug approval in China |
5 China Imatinib Drug Market Trends |
6 China Imatinib Drug Market, By Types |
6.1 China Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 China Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 China Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 China Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 China Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 China Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 China Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 China Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 China Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 China Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 China Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 China Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 China Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 China Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 China Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 China Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 China Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 China Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 China Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 China Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 China Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 China Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 China Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 China Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 China Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 China Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 China Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 China Imatinib Drug Market Import-Export Trade Statistics |
7.1 China Imatinib Drug Market Export to Major Countries |
7.2 China Imatinib Drug Market Imports from Major Countries |
8 China Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare facilities offering imatinib treatment |
8.3 Rate of new cases of CML diagnosed annually in China |
9 China Imatinib Drug Market - Opportunity Assessment |
9.1 China Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 China Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 China Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 China Imatinib Drug Market - Competitive Landscape |
10.1 China Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 China Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here